Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Pharmaceutical and Biotechnology Machines Market by Type (Oxygen, Nitrous Oxide, Medical Air, Others(Nitrogen, Carbon Dioxide and Helium)), By Application (Hospitals (Labs & Clinics), Home Healthcare, Universities/Research Institutions, Pharmaceutical & Biotechnology Industries) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Pharmaceutical and Biotechnology Machines Market by Type (Oxygen, Nitrous Oxide, Medical Air, Others(Nitrogen, Carbon Dioxide and Helium)), By Application (Hospitals (Labs & Clinics), Home Healthcare, Universities/Research Institutions, Pharmaceutical & Biotechnology Industries) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 170108 3300 Medical Devices & Consumables 377 247 Pages 4.7 (31)
                                          

Market Overview:


The global pharmaceutical and biotechnology machines market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for oxygen, nitrous oxide, medical air, and other gases from hospitals (labs & clinics), home healthcare, universities/research institutions, and pharmaceutical & biotechnology industries. Additionally, the growing awareness about the benefits of using these gases is also contributing to the growth of this market. However, factors such as high installation and maintenance costs are restraining its growth. On the basis of type, the global pharmaceutical and biotechnology machines market can be segmented into oxygen gas generators,, nitrous oxide gas generators,, medical air compressors,, nitrogen gas generators,, carbon dioxide gas generators,, helium gas generators,.and others (including argon,.hydrogen,.and krypton). Among these types,.oxygen accounted for a major share in 2017 owing to its widespread use in hospitals for various applications such as respiratory therapy,.anaesthesia delivery systems.,and patient monitoring.Nitrous oxide is also gaining popularity due to its analgesic properties and is being increasingly used in pain management procedures.Medical air compressors are used for supplying compressed medical-grade air or oxygen through pipelines or hoses directly into an operating theatre or anaesthetic workstation.


Global Pharmaceutical and Biotechnology Machines Industry Outlook


Product Definition:


Pharmaceutical and biotechnology machines are used to produce drugs and other medical treatments. They are important because they allow us to create life-saving treatments.


Oxygen:


Oxygen is the third most abundant element on earth. It is a colorless and odorless gas with a boiling point of -38°C and a molecular weight of 28.2 (Air has a molecular weight of 28.0, Nitrogen has a molecular weight of 22.0). Oxygen makes up around 21% by volume in dry air or about 27% by mass in liquid air (N2).


Nitrous Oxide:


Nitrous oxide is a colorless and non-flammable gas with a mild aroma. It is the simplest of all oxides of nitrogen. Nitrous oxide has been used as an insufflation agent in surgical operations since 1844, but only within medical and dental applications until recently when it was found to be useful for recreational purposes also.


Application Insights:


Based on application, the global pharmaceutical and biotechnology machines market has been segmented into hospitals (labs & clinics), home healthcare, universities/research institutions, and pharmaceutical and biotechnology industries. Hospitals (labs & clinics) held the largest share in 2017 owing to increasing demand for technologically advanced equipment by patients to ensure faster diagnosis as well as treatment. Furthermore, an increase in hospital construction projects across the globe is expected to drive growth over the forecast period.


Home healthcare is expected to be one of the fastest-growing segments due largely to rising awareness about available medical devices at consumers¢â‚¬â„¢ level coupled with easy access due to online shopping trends across various regions of the world.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to the presence of a large number of pharmaceutical and biotech companies, which are major end users for these machines. In addition, increasing R&D activities by various companies is also expected to have a positive impact on growth over the forecast period. Asia Pacific is expected to grow at an exponential rate during the forecast period owing to rising healthcare expenditure and improving healthcare infrastructure in this region.


In 2016, China accounted for approximately 40% of revenue share within Asia Pacific region owing to rapid economic development coupled with government initiatives towards improving healthcare facilities across rural areas & small towns as well as urban centers throughout China (Beijing & Shanghai).


Growth Factors:


  • Increasing demand for biopharmaceuticals and biosimilars: The global market for biopharmaceuticals is expected to grow at a CAGR of 12.8% from 2016 to 2021, reaching a value of 2.8 billion by 2021. This growth is primarily attributed to the increasing prevalence of chronic diseases, rising R&D expenditure by pharmaceutical companies, and technological advancements in the field of biotechnology.
  • Growing demand for personalized medicines: The market for personalized medicines is expected to grow at a CAGR of 16% from 2016 to 2021, reaching a value of 3 billion by 2021. This growth can be attributed to the increasing incidence of lifestyle diseases, growing preference for targeted therapies over traditional therapies, and technological advancements in the field of genomics and proteomics research.
  • Rising public-private investments in life sciences sector: There has been an increase in public-private investments in life sciences sector over the past few years due to which there has been an improvement in infrastructure facilities as well as increased availability of funds for R&D activities within this sector .

Scope Of The Report

Report Attributes

Report Details

Report Title

Pharmaceutical and Biotechnology Machines Market Research Report

By Type

Oxygen, Nitrous Oxide, Medical Air, Others(Nitrogen, Carbon Dioxide and Helium)

By Application

Hospitals (Labs & Clinics), Home Healthcare, Universities/Research Institutions, Pharmaceutical & Biotechnology Industries

By Companies

Air Liquide, Linde Healthcare, Praxair, Air Products, Taiyo Nippon Sanso, Matheson Gas, Atlas Copco AB, Messer Group, SOL Group, Norco, Sicgil India Limited, Shenzhen Gaofa, Shenwei Medical, Beijing Orient, Nanning Lantian

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

247

Number of Tables & Figures

173

Customization Available

Yes, the report can be customized as per your need.


Global Pharmaceutical and Biotechnology Machines Market Report Segments:

The global Pharmaceutical and Biotechnology Machines market is segmented on the basis of:

Types

Oxygen, Nitrous Oxide, Medical Air, Others(Nitrogen, Carbon Dioxide and Helium)

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals (Labs & Clinics), Home Healthcare, Universities/Research Institutions, Pharmaceutical & Biotechnology Industries

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Air Liquide
  2. Linde Healthcare
  3. Praxair
  4. Air Products
  5. Taiyo Nippon Sanso
  6. Matheson Gas
  7. Atlas Copco AB
  8. Messer Group
  9. SOL Group
  10. Norco
  11. Sicgil India Limited
  12. Shenzhen Gaofa
  13. Shenwei Medical
  14. Beijing Orient
  15. Nanning Lantian

Global Pharmaceutical and Biotechnology Machines Market Overview


Highlights of The Pharmaceutical and Biotechnology Machines Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Oxygen
    2. Nitrous Oxide
    3. Medical Air
    4. Others(Nitrogen, Carbon Dioxide and Helium)
  1. By Application:

    1. Hospitals (Labs & Clinics)
    2. Home Healthcare
    3. Universities/Research Institutions
    4. Pharmaceutical & Biotechnology Industries
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Pharmaceutical and Biotechnology Machines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Pharmaceutical and Biotechnology Machines Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Pharmaceutical and biotechnology machines are used in the production of pharmaceuticals, medical devices, and other biotech products. These machines help to automate processes such as mixing ingredients, sterilizing equipment, and more.

Some of the major players in the pharmaceutical and biotechnology machines market are Air Liquide, Linde Healthcare, Praxair, Air Products, Taiyo Nippon Sanso, Matheson Gas, Atlas Copco AB, Messer Group, SOL Group, Norco, Sicgil India Limited, Shenzhen Gaofa, Shenwei Medical, Beijing Orient, Nanning Lantian.

The pharmaceutical and biotechnology machines market is expected to register a CAGR of 5.8%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Pharmaceutical and Biotechnology Machines Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Pharmaceutical and Biotechnology Machines Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Pharmaceutical and Biotechnology Machines Market - Supply Chain
   4.5. Global Pharmaceutical and Biotechnology Machines Market Forecast
      4.5.1. Pharmaceutical and Biotechnology Machines Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Pharmaceutical and Biotechnology Machines Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Pharmaceutical and Biotechnology Machines Market Absolute $ Opportunity

5. Global Pharmaceutical and Biotechnology Machines Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Type
      5.3.1. Oxygen
      5.3.2. Nitrous Oxide
      5.3.3. Medical Air
      5.3.4. Others(Nitrogen, Carbon Dioxide and Helium)
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Pharmaceutical and Biotechnology Machines Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Application
      6.3.1. Hospitals (Labs & Clinics)
      6.3.2. Home Healthcare
      6.3.3. Universities/Research Institutions
      6.3.4. Pharmaceutical & Biotechnology Industries
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Pharmaceutical and Biotechnology Machines Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Pharmaceutical and Biotechnology Machines Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Pharmaceutical and Biotechnology Machines Demand Share Forecast, 2019-2026

9. North America Pharmaceutical and Biotechnology Machines Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Application
      9.4.1. Hospitals (Labs & Clinics)
      9.4.2. Home Healthcare
      9.4.3. Universities/Research Institutions
      9.4.4. Pharmaceutical & Biotechnology Industries
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Type
      9.7.1. Oxygen
      9.7.2. Nitrous Oxide
      9.7.3. Medical Air
      9.7.4. Others(Nitrogen, Carbon Dioxide and Helium)
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Pharmaceutical and Biotechnology Machines Demand Share Forecast, 2019-2026

10. Latin America Pharmaceutical and Biotechnology Machines Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Application
      10.4.1. Hospitals (Labs & Clinics)
      10.4.2. Home Healthcare
      10.4.3. Universities/Research Institutions
      10.4.4. Pharmaceutical & Biotechnology Industries
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Type
      10.7.1. Oxygen
      10.7.2. Nitrous Oxide
      10.7.3. Medical Air
      10.7.4. Others(Nitrogen, Carbon Dioxide and Helium)
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Pharmaceutical and Biotechnology Machines Demand Share Forecast, 2019-2026

11. Europe Pharmaceutical and Biotechnology Machines Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Application
      11.4.1. Hospitals (Labs & Clinics)
      11.4.2. Home Healthcare
      11.4.3. Universities/Research Institutions
      11.4.4. Pharmaceutical & Biotechnology Industries
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Type
      11.7.1. Oxygen
      11.7.2. Nitrous Oxide
      11.7.3. Medical Air
      11.7.4. Others(Nitrogen, Carbon Dioxide and Helium)
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Pharmaceutical and Biotechnology Machines Demand Share, 2019-2026

12. Asia Pacific Pharmaceutical and Biotechnology Machines Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Application
      12.4.1. Hospitals (Labs & Clinics)
      12.4.2. Home Healthcare
      12.4.3. Universities/Research Institutions
      12.4.4. Pharmaceutical & Biotechnology Industries
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Type
      12.7.1. Oxygen
      12.7.2. Nitrous Oxide
      12.7.3. Medical Air
      12.7.4. Others(Nitrogen, Carbon Dioxide and Helium)
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Pharmaceutical and Biotechnology Machines Demand Share, 2019-2026

13. Middle East & Africa Pharmaceutical and Biotechnology Machines Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Application
      13.4.1. Hospitals (Labs & Clinics)
      13.4.2. Home Healthcare
      13.4.3. Universities/Research Institutions
      13.4.4. Pharmaceutical & Biotechnology Industries
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Pharmaceutical and Biotechnology Machines Market Size and Volume Forecast by Type
      13.7.1. Oxygen
      13.7.2. Nitrous Oxide
      13.7.3. Medical Air
      13.7.4. Others(Nitrogen, Carbon Dioxide and Helium)
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Pharmaceutical and Biotechnology Machines Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Pharmaceutical and Biotechnology Machines Market: Market Share Analysis
   14.2. Pharmaceutical and Biotechnology Machines Distributors and Customers
   14.3. Pharmaceutical and Biotechnology Machines Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Air Liquide
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Linde Healthcare
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Praxair
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Air Products
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Taiyo Nippon Sanso
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Matheson Gas
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Atlas Copco AB
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Messer Group
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. SOL Group
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Norco
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Sicgil India Limited
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Shenzhen Gaofa
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Shenwei Medical
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Beijing Orient
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Nanning Lantian
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us